US President Donald Trump called Prime Minister Narendra Modi to ask him to release shipments of Hydroxychloroquine tablets hoping they might be a “game-changer” in the fight against Covid-19. Whether they work or not, that call underscored how the pandemic has turned the world order upside down. As a new immigrant in America in the…
Coronavirus pandemic has killed over 4.7 lakh people across the globe. In India, the death toll is over 13,000. The good news is that DGCI has given nod to 3 companies to roll out their COVID-19 treatment medicine in India. These companies are — Cipla, Glenmark and Hetero. And the three medicines are called Cipremi, FabiFlu…
NEW DELHI : Having received the manufacturing and marketing approval from the Drugs Controller General of India (DCGI), drug firm Glenmark Pharmaceuticals has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 patients. Price at ₹103 per tablet, the prescription-based drug will be available as a 200…
HYDERABAD: Aurobindo Pharma, Sun Pharma and Lupin are among the 26 drug makers facing a multi-state lawsuit filed in USA by Maryland Attorney General for alleged “conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States.” Attorney General Brian E Frosh in a statement issued on Wednesday said the new complaint,…
The government had banned the export of these testing kits to cater to local demand. ICMR has validated the RT-PCR test kits made by 40 domestic and multinational companies for local supply. However, as India’s Covid-19 case load rises every day, companies are reporting that state governments and ICMR have halted procurement of test kits. “We…
US President Donald Trump called Prime Minister Narendra Modi to ask him to release shipments of Hydroxychloroquine tablets hoping they might be a “game-changer” in the fight against Covid-19. Whether they work or not, that call underscored how the pandemic has turned the world order upside down. As a new immigrant in America in the…
Coronavirus pandemic has killed over 4.7 lakh people across the globe. In India, the death toll is over 13,000. The good news is that DGCI has given nod to 3 companies to roll out their COVID-19 treatment medicine in India. These companies are — Cipla, Glenmark and Hetero. And the three medicines are called Cipremi, FabiFlu…
NEW DELHI : Having received the manufacturing and marketing approval from the Drugs Controller General of India (DCGI), drug firm Glenmark Pharmaceuticals has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 patients. Price at ₹103 per tablet, the prescription-based drug will be available as a 200…
HYDERABAD: Aurobindo Pharma, Sun Pharma and Lupin are among the 26 drug makers facing a multi-state lawsuit filed in USA by Maryland Attorney General for alleged “conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States.” Attorney General Brian E Frosh in a statement issued on Wednesday said the new complaint,…
The government had banned the export of these testing kits to cater to local demand. ICMR has validated the RT-PCR test kits made by 40 domestic and multinational companies for local supply. However, as India’s Covid-19 case load rises every day, companies are reporting that state governments and ICMR have halted procurement of test kits. “We…
The charges, if proven, may incur huge litigation and financial burden on the companies, experts sid. Others mentioned in the complaint include Mumbai-based companies Wockhardt and Glenmark. The fresh lawsuit, a copy of which is available with TOI, clocks over 500 pages and has been filed on June 10 by over 40 US states. It…